Status:
UNKNOWN
Prevalence of Attention Deficit Hyperactivity Disorder and Its Comorbidities
Lead Sponsor:
Assiut University
Conditions:
ADHD
Eligibility:
All Genders
6-17 years
Brief Summary
Estimate the prevalence of attention deficit hyperactivity disorder and comorbid psychiatric disorder among primary school students in New Valley governorate.
Detailed Description
ADHD (attention deficit hyperactivity disorder) is a common neurodevelopmental disorder characterized by hyperactivity, impulsivity, and inattention. Its prevalence ranges between 5.9 and 7.1% worldwi...
Eligibility Criteria
Inclusion
- Age: 6-17 years. Sex: both sexes will be included in the study.
Exclusion
- Age: less than 6 years or more than 17 years. Patients with major neurological deficits, cerebral palsy. Patient who refusing to participate in the study or their caregiver refusing to give informed consent. Mentally retarded children.
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06146595
Start Date
February 1 2024
End Date
November 1 2025
Last Update
November 24 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.